DOD PCRP Gets Funded for the 2014 Budget Year
I have often discussed the importance of the Prostate Cancer Research Program (PCRP), which is a part of the Department of Defense (DOD) Medical Research Program. The program is geared to delivering funding for prostate [...]
Should Provenge be Used Before or After ADT in Men with Biochemical Prostate Cancer Recurrence?
Sequencing of the various new advanced prostate cancer treatments remains a hot topic in our community. What treatment should come first and will the combination of various treatments be even more effective? These types of [...]
Start A Cure- Molecular Radiotherapy for Metastatic Prostate Cancer – A Project for You to Fund
A few days ago I wrote about Malecare’s new program addition, Start A Cure in my post “Announcing A New Research Platform – Start A Cure.” The program goal is to raise funding for cancer [...]
Xtandi Will Hopefully be Quickly Approved in Japan
Some good news for men who are living in Japan and dealing with advanced prostate cancer. It was announced that Astellas and Medivation have submitted an application for marketing approval of Enzalutamide (Xtandi) in Japan. [...]
Important – Read the Prescribing Information that Comes with Your Medications
The following is a post from Chuck Maack on the Advanced Prostate Cancer Internet support group: “It came to mind wondering how many patients and/or their caregivers prescribed Zytiga/abiraterone acetate have ever taken the important [...]
Announcing A New Research Platform – Start A Cure
The news is in, and it is bad. It is as bad as many of us feared. The National Institute of Health (NIH) has announced that their across-the-board budget sequester cuts are going to equal [...]